This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07903/identifier/pubchem-compound/
dctermshttp://purl.org/dc/terms/
n5http://linked.opendata.cz/resource/drugbank/drug/DB07903/identifier/pubchem-substance/
n6http://linked.opendata.cz/resource/drugbank/drug/DB07903/identifier/drugbank/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://linked.opendata.cz/resource/drugbank/drug/DB07903/identifier/chemspider/
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n8http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n7http://linked.opendata.cz/resource/drugbank/drug/DB07903/identifier/pdb/

Statements

Subject Item
n2:DB07903
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n10:DB07903 n12:DB07903
dcterms:title
3-[(2,2-DIMETHYLPROPANOYL)AMINO]-N-1,3-THIAZOL-2-YLPYRIDINE-2-CARBOXAMIDE
adms:identifier
n5:99444374 n6:DB07903 n7:HM5 n13:9295382 n14:11120251
n3:IUPAC-Name
n8:271B4AAE-363D-11E5-9242-09173F13E4C5
n3:InChI
n8:271B4AB4-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n8:271B4AB3-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n8:271B4AB0-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n8:271B4AB1-363D-11E5-9242-09173F13E4C5
n3:SMILES
n8:271B4AB2-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n8:271B4AAC-363D-11E5-9242-09173F13E4C5
n3:logP
n8:271B4AAD-363D-11E5-9242-09173F13E4C5 n8:271B4AAA-363D-11E5-9242-09173F13E4C5
n3:logS
n8:271B4AAB-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n8:271B4ABA-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n8:271B4ABB-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n8:271B4AB5-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n8:271B4AB6-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n8:271B4AB8-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n8:271B4AB7-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n8:271B4AB9-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n8:271B4AC0-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n8:271B4AC2-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n8:271B4AC3-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n8:271B4ABF-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n8:271B4ABE-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n8:271B4AC1-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n8:271B4AAF-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n8:271B4ABC-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n8:271B4ABD-363D-11E5-9242-09173F13E4C5